Fungi directly affect the health of animals and humans as pathogens, particularly in immunologically compromised individuals. They also are responsible for causing disease and spoilage of food crops that indirectly impact human health. An understanding of the molecular mechanisms governing gene expression in the filamentous fungi will help provide the insight needed to develop strategies against fungal infection of living organisms. Asexual development is a critical phase in the fife cycle of most fungi. This project will focus on understanding the interaction of development and gene expression. The filamentous ascomycete Neurospora crassa is particularly suited for these studies because of the wealth of genetic and biochemical data available and its simple development during asexual spore formation. Recent progress in applying molecular biological approaches to the study of N. crassa has greatly facilitated examination of asexual development. N. crassa is one of the most highly developed systems for analyzing gene expression in filamentous fungi. The specific goal of this project is to determine the genetic regulatory mechanisms involved in controlling asexual development in N. crassa. Promoter analyses will identify DNA sequence elements required for developmental expression of genes. Biochemical analyses of protein factors that bind to these DNA sequences will precisely define the interaction of cis- and trans-acting regulatory elements. In a complementary approach, mutants that are altered in the temporal or spatial regulation of developmentally expressed genes will be isolated. Characterization of these mutants will define the regulatory network involved in controlling spore formation in this fungus. This work will also contribute to our general understanding of gene expression in eukaryotic organisms.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29GM047977-03
Application #
2185406
Study Section
Microbial Physiology and Genetics Subcommittee 2 (MBC)
Project Start
1992-08-01
Project End
1997-07-31
Budget Start
1994-08-01
Budget End
1995-07-31
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Texas A&M University
Department
Pathology
Type
Schools of Medicine
DUNS #
City
College Station
State
TX
Country
United States
Zip Code
77845
Shrode, L B; Lewis, Z A; White, L D et al. (2001) vvd is required for light adaptation of conidiation-specific genes of Neurospora crassa, but not circadian conidiation. Fungal Genet Biol 32:169-81
Bailey, L A; Ebbole, D J (1998) The fluffy gene of Neurospora crassa encodes a Gal4p-type C6 zinc cluster protein required for conidial development. Genetics 148:1813-20
Lee, K; Ebbole, D J (1998) Tissue-specific repression of starvation and stress responses of the Neurospora crassa con-10 gene is mediated by RCO1. Fungal Genet Biol 23:269-78
Lee, K; Ebbole, D J (1998) Analysis of two transcription activation elements in the promoter of the developmentally regulated con-10 gene of Neurospora crassa. Fungal Genet Biol 23:259-68
Shen, W C; Wieser, J; Adams, T H et al. (1998) The Neurospora rca-1 gene complements an Aspergillus flbD sporulation mutant but has no identifiable role in Neurospora sporulation. Genetics 148:1031-41
Shen, W C; Ebbole, D J (1997) Cross-pathway and pathway-specific control of amino acid biosynthesis in Magnaporthe grisea. Fungal Genet Biol 21:40-9
Ebbole, D J (1997) Hydrophobins and fungal infection of plants and animals. Trends Microbiol 5:405-8
Beckerman, J L; Naider, F; Ebbole, D J (1997) Inhibition of pathogenicity of the rice blast fungus by Saccharomyces cerevisiae alpha-factor. Science 276:1116-9
Beckerman, J L; Ebbole, D J (1996) MPG1, a gene encoding a fungal hydrophobin of Magnaporthe grisea, is involved in surface recognition. Mol Plant Microbe Interact 9:450-6
Madi, L; Ebbole, D J; White, B T et al. (1994) Mutants of Neurospora crassa that alter gene expression and conidia development. Proc Natl Acad Sci U S A 91:6226-30